U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C12H13Cl2N5
Molecular Weight 298.171
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PALATRIGINE

SMILES

CC(C)N1N=C(C(N)=NC1=N)C2=C(Cl)C(Cl)=CC=C2

InChI

InChIKey=XJQJAFGEQVKYNF-UHFFFAOYSA-N
InChI=1S/C12H13Cl2N5/c1-6(2)19-12(16)17-11(15)10(18-19)7-4-3-5-8(13)9(7)14/h3-6H,1-2H3,(H3,15,16,17)

HIDE SMILES / InChI

Molecular Formula C12H13Cl2N5
Molecular Weight 298.171
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Palatrigine (also known as BW A256C) was developed and classified as a novel "slow" class 1C antiarrhythmic agent. Information about the current use of this drug is not available.

Approval Year

PubMed

Substance Class Chemical
Record UNII
E8614FE04U
Record Status Validated (UNII)
Record Version